Effects on Insulin Secretion and Sensitivity of Two Different Formulations Tacrolimus - Prograf and Advagraf.

Trial Profile

Effects on Insulin Secretion and Sensitivity of Two Different Formulations Tacrolimus - Prograf and Advagraf.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Oct 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 21 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top